` 1011 (China NT Pharma Group Company Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

C
1011
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, China NT Pharma Group Company Ltd has significantly outperformed Hang Seng (Hong Kong), delivering a return of +196% compared to the Hang Seng (Hong Kong)'s +7% growth.

Stocks Performance
1011 vs Hang Seng (Hong Kong)

Loading
1011
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
1011 vs Hang Seng (Hong Kong)

Loading
1011
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
1011 vs Hang Seng (Hong Kong)

Loading
1011
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
China NT Pharma Group Company Ltd vs Peers

Hang Seng (Hong Kong)
1011
JEF
JNJ
4312
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

China NT Pharma Group Company Ltd
Glance View

Market Cap
478.7m HKD
Industry
Pharmaceuticals

China NT Pharma Group Co., Ltd. is a pharmaceutical company, which engages in the distribution, promotion, manufacturing as well as research and development of pharmaceuticals and vaccines. The company is headquartered in Suzhou, Jiangsu. The company went IPO on 2011-04-20. The firm mainly conducts its businesses through two segments. The Proprietary Product Production and Sales segment is engaged in the production and sales of NT branded products and generic drugs through its subsidiaries. The Miacalcic segment is engaged in the sales and marketing of miacalcic injectable and nasal spray branded products for treatment of bone pain caused by osteolysis and lower bone mass, as well as sub-licensing of intellectual property rights and distribution rights.

Intrinsic Value
0.45 HKD
Overvaluation 37%
Intrinsic Value
Price HK$0.71
C
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett